 Xiyuan Bai
Concepts (291)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mycobacterium tuberculosis | 14 | 2024 | 337 | 3.640 |
Why?
| | Tuberculosis | 12 | 2024 | 291 | 3.070 |
Why?
| | alpha 1-Antitrypsin | 5 | 2024 | 102 | 2.650 |
Why?
| | Interleukins | 8 | 2019 | 248 | 2.080 |
Why?
| | Macrophages, Alveolar | 5 | 2019 | 368 | 1.640 |
Why?
| | alpha 1-Antitrypsin Deficiency | 4 | 2023 | 59 | 1.560 |
Why?
| | Macrophages | 11 | 2024 | 1496 | 1.550 |
Why?
| | Receptors, Glucocorticoid | 2 | 2024 | 130 | 1.420 |
Why?
| | Mycobacterium avium Complex | 4 | 2021 | 88 | 1.030 |
Why?
| | Mycobacterium avium-intracellulare Infection | 2 | 2019 | 63 | 0.880 |
Why?
| | NF-kappa B | 6 | 2022 | 657 | 0.760 |
Why?
| | Nicotine | 3 | 2023 | 334 | 0.720 |
Why?
| | Cigarette Smoking | 1 | 2023 | 99 | 0.720 |
Why?
| | Apoptosis | 5 | 2020 | 2397 | 0.690 |
Why?
| | Enoxaparin | 1 | 2022 | 68 | 0.680 |
Why?
| | Mycobacterium Infections, Nontuberculous | 8 | 2021 | 368 | 0.580 |
Why?
| | Interferon-gamma | 6 | 2015 | 781 | 0.520 |
Why?
| | T-Lymphocytes, Regulatory | 4 | 2023 | 394 | 0.490 |
Why?
| | Tuberculosis, Pulmonary | 4 | 2017 | 131 | 0.470 |
Why?
| | Testis | 2 | 2009 | 162 | 0.460 |
Why?
| | Curcumin | 1 | 2016 | 27 | 0.460 |
Why?
| | Autophagy | 4 | 2021 | 284 | 0.450 |
Why?
| | Nontuberculous Mycobacteria | 5 | 2018 | 210 | 0.410 |
Why?
| | Microbial Viability | 2 | 2013 | 91 | 0.400 |
Why?
| | Models, Biological | 1 | 2020 | 1811 | 0.380 |
Why?
| | Chemokine CXCL10 | 2 | 2010 | 39 | 0.380 |
Why?
| | Smoking | 5 | 2020 | 1467 | 0.360 |
Why?
| | Monocytes | 2 | 2011 | 536 | 0.340 |
Why?
| | Casein Kinase II | 2 | 2009 | 22 | 0.340 |
Why?
| | Cell Line | 6 | 2017 | 2821 | 0.340 |
Why?
| | Chemokine CXCL9 | 1 | 2010 | 38 | 0.330 |
Why?
| | Serine Endopeptidases | 2 | 2022 | 129 | 0.320 |
Why?
| | Respiratory System | 1 | 2011 | 151 | 0.320 |
Why?
| | Lung Diseases | 4 | 2021 | 781 | 0.310 |
Why?
| | Humans | 38 | 2024 | 144667 | 0.300 |
Why?
| | Granuloma | 2 | 2024 | 96 | 0.290 |
Why?
| | Epithelial Cells | 3 | 2018 | 1106 | 0.290 |
Why?
| | Anti-Inflammatory Agents | 2 | 2022 | 477 | 0.270 |
Why?
| | Disease Susceptibility | 5 | 2018 | 342 | 0.250 |
Why?
| | Serine Proteinase Inhibitors | 3 | 2024 | 48 | 0.250 |
Why?
| | Smoke | 2 | 2020 | 147 | 0.250 |
Why?
| | Phosphoproteins | 1 | 2009 | 339 | 0.250 |
Why?
| | Dendritic Cells | 2 | 2021 | 498 | 0.240 |
Why?
| | Protein Subunits | 3 | 2017 | 228 | 0.240 |
Why?
| | Interleukin-8 | 2 | 2022 | 269 | 0.230 |
Why?
| | Cytokines | 5 | 2024 | 2045 | 0.230 |
Why?
| | Heparin | 2 | 2024 | 243 | 0.220 |
Why?
| | THP-1 Cells | 1 | 2024 | 20 | 0.210 |
Why?
| | Cells, Cultured | 6 | 2019 | 4110 | 0.210 |
Why?
| | Tumor Necrosis Factor-alpha | 4 | 2015 | 1207 | 0.210 |
Why?
| | Serpins | 1 | 2024 | 28 | 0.200 |
Why?
| | Lipopolysaccharides | 2 | 2022 | 854 | 0.200 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2024 | 161 | 0.190 |
Why?
| | Molecular Epidemiology | 1 | 2023 | 73 | 0.190 |
Why?
| | Th1 Cells | 1 | 2004 | 139 | 0.190 |
Why?
| | Th2 Cells | 1 | 2004 | 171 | 0.190 |
Why?
| | Angiopoietins | 1 | 2022 | 12 | 0.190 |
Why?
| | Nuclear Proteins | 2 | 2009 | 741 | 0.190 |
Why?
| | Pancreatic Elastase | 1 | 2022 | 53 | 0.190 |
Why?
| | Animals | 18 | 2024 | 37948 | 0.190 |
Why?
| | Microtubule-Associated Proteins | 1 | 2003 | 195 | 0.180 |
Why?
| | Immunity, Innate | 3 | 2018 | 843 | 0.180 |
Why?
| | Autophagosomes | 2 | 2021 | 20 | 0.170 |
Why?
| | Adaptive Immunity | 3 | 2024 | 169 | 0.170 |
Why?
| | Adipokines | 2 | 2019 | 57 | 0.170 |
Why?
| | Virus Internalization | 1 | 2020 | 65 | 0.160 |
Why?
| | Leukocyte Elastase | 1 | 2020 | 73 | 0.160 |
Why?
| | Radiation Tolerance | 1 | 2021 | 103 | 0.160 |
Why?
| | Extracellular Traps | 1 | 2020 | 51 | 0.160 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2003 | 454 | 0.160 |
Why?
| | Antithrombins | 1 | 2020 | 69 | 0.160 |
Why?
| | Mice | 11 | 2023 | 18261 | 0.160 |
Why?
| | Orotate Phosphoribosyltransferase | 1 | 1999 | 3 | 0.150 |
Why?
| | Kluyveromyces | 1 | 1999 | 10 | 0.150 |
Why?
| | Genes, Fungal | 1 | 1999 | 55 | 0.150 |
Why?
| | HEK293 Cells | 1 | 2022 | 743 | 0.150 |
Why?
| | Adipose Tissue, White | 1 | 2019 | 42 | 0.150 |
Why?
| | Phagosomes | 1 | 2019 | 40 | 0.150 |
Why?
| | Vitamin A | 1 | 2019 | 59 | 0.150 |
Why?
| | Gene Expression Regulation | 2 | 2024 | 2591 | 0.150 |
Why?
| | Transcription Factor RelA | 1 | 2019 | 85 | 0.140 |
Why?
| | Mycobacterium | 2 | 2010 | 116 | 0.140 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2021 | 201 | 0.140 |
Why?
| | Leishmania infantum | 1 | 2018 | 8 | 0.140 |
Why?
| | Emphysema | 1 | 2019 | 100 | 0.140 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 973 | 0.140 |
Why?
| | Macrophage Activation | 1 | 2019 | 186 | 0.140 |
Why?
| | Leishmaniasis, Visceral | 1 | 2018 | 24 | 0.140 |
Why?
| | Lung | 6 | 2021 | 4089 | 0.140 |
Why?
| | Bronchiectasis | 1 | 2019 | 112 | 0.130 |
Why?
| | Protective Factors | 1 | 2018 | 99 | 0.130 |
Why?
| | Interleukin-4 | 3 | 2009 | 206 | 0.130 |
Why?
| | Interleukin-12 | 2 | 2011 | 117 | 0.130 |
Why?
| | Adipocytes | 1 | 2019 | 223 | 0.130 |
Why?
| | Nicotinic Antagonists | 1 | 2017 | 37 | 0.130 |
Why?
| | Gene Expression | 3 | 2011 | 1476 | 0.130 |
Why?
| | Acute Lung Injury | 1 | 2020 | 301 | 0.130 |
Why?
| | Cell-Free Nucleic Acids | 1 | 2017 | 32 | 0.130 |
Why?
| | Mice, Transgenic | 3 | 2019 | 2184 | 0.120 |
Why?
| | Virulence Factors | 1 | 2018 | 177 | 0.120 |
Why?
| | Spermatids | 2 | 2009 | 25 | 0.120 |
Why?
| | Two-Hybrid System Techniques | 2 | 2009 | 59 | 0.120 |
Why?
| | Transforming Growth Factor beta | 2 | 2013 | 475 | 0.120 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2017 | 339 | 0.120 |
Why?
| | Anti-Bacterial Agents | 5 | 2015 | 1928 | 0.120 |
Why?
| | Immunotherapy | 1 | 2021 | 662 | 0.120 |
Why?
| | Protective Agents | 1 | 2016 | 42 | 0.120 |
Why?
| | DNA, Bacterial | 1 | 2017 | 347 | 0.120 |
Why?
| | Head and Neck Neoplasms | 1 | 2021 | 562 | 0.120 |
Why?
| | Models, Immunological | 1 | 2016 | 100 | 0.120 |
Why?
| | NK Cell Lectin-Like Receptor Subfamily B | 1 | 2015 | 9 | 0.110 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2021 | 881 | 0.110 |
Why?
| | Antigens, Ly | 1 | 2015 | 40 | 0.110 |
Why?
| | Respiratory Mucosa | 1 | 2018 | 322 | 0.110 |
Why?
| | RNA Splice Sites | 1 | 2015 | 52 | 0.110 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 1 | 2015 | 45 | 0.110 |
Why?
| | Bacterial Load | 1 | 2015 | 67 | 0.110 |
Why?
| | Receptors, Nicotinic | 1 | 2017 | 328 | 0.110 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2015 | 81 | 0.110 |
Why?
| | Antiviral Agents | 1 | 2020 | 765 | 0.110 |
Why?
| | Transgenes | 1 | 2015 | 191 | 0.100 |
Why?
| | Cytoplasm | 1 | 2015 | 257 | 0.100 |
Why?
| | Mycobacterium Infections | 3 | 2010 | 61 | 0.100 |
Why?
| | Lymph Nodes | 2 | 2015 | 501 | 0.100 |
Why?
| | Immunohistochemistry | 2 | 2011 | 1705 | 0.100 |
Why?
| | Latent Tuberculosis | 1 | 2015 | 71 | 0.100 |
Why?
| | Virulence | 1 | 2015 | 282 | 0.100 |
Why?
| | Biofilms | 2 | 2014 | 301 | 0.100 |
Why?
| | Biomimetic Materials | 1 | 2014 | 78 | 0.100 |
Why?
| | Respiratory Tract Infections | 1 | 2018 | 395 | 0.100 |
Why?
| | Acanthamoeba | 1 | 2013 | 5 | 0.100 |
Why?
| | Mycobacterium avium | 1 | 2013 | 21 | 0.100 |
Why?
| | Interleukin-18 | 2 | 2011 | 234 | 0.100 |
Why?
| | Intracellular Space | 1 | 2013 | 64 | 0.090 |
Why?
| | Caspase Inhibitors | 1 | 2013 | 80 | 0.090 |
Why?
| | Cell Movement | 1 | 2017 | 959 | 0.090 |
Why?
| | Transfection | 1 | 2015 | 924 | 0.090 |
Why?
| | Sulfones | 1 | 2013 | 127 | 0.090 |
Why?
| | Water Microbiology | 1 | 2013 | 93 | 0.090 |
Why?
| | Water Supply | 1 | 2013 | 90 | 0.090 |
Why?
| | Adenoviridae | 1 | 2013 | 199 | 0.090 |
Why?
| | Caspase 3 | 1 | 2013 | 234 | 0.090 |
Why?
| | Nitriles | 1 | 2013 | 205 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1700 | 0.090 |
Why?
| | Amikacin | 1 | 2011 | 29 | 0.090 |
Why?
| | Lipid Metabolism | 1 | 2015 | 524 | 0.090 |
Why?
| | Blotting, Northern | 1 | 2010 | 203 | 0.080 |
Why?
| | RNA, Small Interfering | 2 | 2010 | 631 | 0.080 |
Why?
| | Blotting, Western | 2 | 2010 | 1161 | 0.080 |
Why?
| | Environmental Exposure | 1 | 2015 | 574 | 0.080 |
Why?
| | Case-Control Studies | 3 | 2013 | 3603 | 0.080 |
Why?
| | Lipids | 1 | 2015 | 706 | 0.080 |
Why?
| | In Situ Nick-End Labeling | 1 | 2010 | 120 | 0.080 |
Why?
| | Mice, Inbred BALB C | 3 | 2021 | 1251 | 0.080 |
Why?
| | Base Sequence | 3 | 2003 | 2177 | 0.080 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 265 | 0.080 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2015 | 915 | 0.070 |
Why?
| | Transcriptional Activation | 1 | 2010 | 372 | 0.070 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2015 | 1129 | 0.070 |
Why?
| | Mycoplasma pneumoniae | 1 | 2008 | 53 | 0.070 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2008 | 55 | 0.070 |
Why?
| | Up-Regulation | 1 | 2010 | 848 | 0.070 |
Why?
| | Amino Acid Sequence | 2 | 2003 | 2136 | 0.070 |
Why?
| | Interleukin-1beta | 1 | 2009 | 390 | 0.070 |
Why?
| | Molecular Sequence Data | 2 | 2003 | 2909 | 0.060 |
Why?
| | Mycobacteriaceae | 1 | 2007 | 35 | 0.060 |
Why?
| | Bronchi | 1 | 2008 | 263 | 0.060 |
Why?
| | In Situ Hybridization | 2 | 2003 | 318 | 0.060 |
Why?
| | Interleukin-10 | 2 | 2008 | 310 | 0.060 |
Why?
| | Obesity | 1 | 2019 | 3070 | 0.060 |
Why?
| | Disease Models, Animal | 3 | 2014 | 4539 | 0.050 |
Why?
| | Mice, Inbred C57BL | 4 | 2021 | 5967 | 0.050 |
Why?
| | Phosphorylation | 1 | 2009 | 1704 | 0.050 |
Why?
| | Cell Membrane | 1 | 2008 | 706 | 0.050 |
Why?
| | Nitric Oxide | 1 | 2009 | 894 | 0.050 |
Why?
| | Chemokines, CXC | 1 | 2004 | 68 | 0.050 |
Why?
| | Serine Proteases | 1 | 2024 | 26 | 0.050 |
Why?
| | t-Complex Genome Region | 1 | 2003 | 3 | 0.050 |
Why?
| | Mutation | 1 | 2015 | 4081 | 0.050 |
Why?
| | Testicular Hormones | 1 | 2003 | 8 | 0.050 |
Why?
| | Oxidative Stress | 1 | 2010 | 1338 | 0.050 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2003 | 17 | 0.050 |
Why?
| | Dyneins | 1 | 2003 | 35 | 0.050 |
Why?
| | Spermatogenesis | 1 | 2003 | 91 | 0.050 |
Why?
| | Thrombin | 1 | 2024 | 167 | 0.050 |
Why?
| | Tissue Distribution | 1 | 2003 | 335 | 0.050 |
Why?
| | Sequence Alignment | 1 | 2003 | 371 | 0.050 |
Why?
| | Spermatozoa | 1 | 2003 | 107 | 0.050 |
Why?
| | Phenotype | 3 | 2021 | 3147 | 0.040 |
Why?
| | Cell Differentiation | 1 | 2010 | 2037 | 0.040 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2003 | 191 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2024 | 369 | 0.040 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2021 | 23 | 0.040 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2021 | 42 | 0.040 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2021 | 80 | 0.040 |
Why?
| | Autophagy-Related Proteins | 1 | 2021 | 46 | 0.040 |
Why?
| | Lymphocyte Depletion | 1 | 2021 | 133 | 0.040 |
Why?
| | Biological Assay | 1 | 2021 | 128 | 0.040 |
Why?
| | Lysosomes | 1 | 2021 | 128 | 0.040 |
Why?
| | Male | 8 | 2019 | 72431 | 0.040 |
Why?
| | Tumor Burden | 1 | 2021 | 324 | 0.040 |
Why?
| | 3-Hydroxysteroid Dehydrogenases | 1 | 2019 | 8 | 0.040 |
Why?
| | Retinal Dehydrogenase | 1 | 2019 | 29 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 835 | 0.040 |
Why?
| | Culture Media, Conditioned | 1 | 2019 | 111 | 0.040 |
Why?
| | Cloning, Molecular | 1 | 1999 | 535 | 0.040 |
Why?
| | Anticoagulants | 1 | 2024 | 729 | 0.030 |
Why?
| | Hyperinsulinism | 1 | 2019 | 114 | 0.030 |
Why?
| | B-Lymphocytes | 1 | 2004 | 875 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2021 | 1268 | 0.030 |
Why?
| | Leptin | 1 | 2019 | 247 | 0.030 |
Why?
| | Repressor Proteins | 1 | 2021 | 428 | 0.030 |
Why?
| | Signal Transduction | 1 | 2010 | 5185 | 0.030 |
Why?
| | Tumor Microenvironment | 1 | 2021 | 729 | 0.030 |
Why?
| | Female | 7 | 2017 | 78304 | 0.030 |
Why?
| | Models, Animal | 1 | 2018 | 393 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2003 | 1484 | 0.030 |
Why?
| | Metabolic Syndrome | 1 | 2019 | 354 | 0.030 |
Why?
| | Cathelicidins | 1 | 2015 | 41 | 0.030 |
Why?
| | Energy-Generating Resources | 1 | 2015 | 6 | 0.030 |
Why?
| | Body Weight | 1 | 2019 | 968 | 0.030 |
Why?
| | Biomass | 1 | 2015 | 117 | 0.030 |
Why?
| | Middle Aged | 3 | 2012 | 35971 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2014 | 123 | 0.030 |
Why?
| | Tobacco Products | 1 | 2015 | 84 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2021 | 3109 | 0.030 |
Why?
| | United States | 1 | 2011 | 16018 | 0.030 |
Why?
| | Microbial Sensitivity Tests | 1 | 2015 | 373 | 0.030 |
Why?
| | Drug Resistance, Bacterial | 1 | 2015 | 205 | 0.020 |
Why?
| | Fibrillins | 1 | 2013 | 9 | 0.020 |
Why?
| | Hartmannella | 1 | 2013 | 2 | 0.020 |
Why?
| | Surface Properties | 1 | 2014 | 397 | 0.020 |
Why?
| | Marfan Syndrome | 1 | 2013 | 46 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2021 | 3523 | 0.020 |
Why?
| | Funnel Chest | 1 | 2012 | 29 | 0.020 |
Why?
| | Tobacco Smoke Pollution | 1 | 2015 | 227 | 0.020 |
Why?
| | Microfilament Proteins | 1 | 2013 | 136 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2017 | 1995 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2013 | 245 | 0.020 |
Why?
| | Drinking Water | 1 | 2013 | 91 | 0.020 |
Why?
| | Aged | 1 | 2011 | 25955 | 0.020 |
Why?
| | Glutathione Peroxidase | 1 | 2010 | 39 | 0.020 |
Why?
| | Free Radical Scavengers | 1 | 2010 | 82 | 0.020 |
Why?
| | Catalase | 1 | 2010 | 133 | 0.020 |
Why?
| | Scoliosis | 1 | 2012 | 224 | 0.020 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2010 | 195 | 0.020 |
Why?
| | Acetylcysteine | 1 | 2010 | 136 | 0.020 |
Why?
| | Interferon Regulatory Factor-1 | 1 | 2009 | 17 | 0.020 |
Why?
| | STAT6 Transcription Factor | 1 | 2009 | 24 | 0.020 |
Why?
| | Biomarkers | 1 | 2021 | 4261 | 0.020 |
Why?
| | Arginase | 1 | 2009 | 25 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2010 | 268 | 0.020 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2009 | 161 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2010 | 762 | 0.020 |
Why?
| | Environment | 1 | 2010 | 306 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 2010 | 303 | 0.020 |
Why?
| | Down-Regulation | 1 | 2010 | 616 | 0.020 |
Why?
| | Adipose Tissue | 1 | 2012 | 643 | 0.020 |
Why?
| | Arginine | 1 | 2009 | 238 | 0.020 |
Why?
| | Hospitals | 1 | 2013 | 729 | 0.020 |
Why?
| | Guinea Pigs | 1 | 2008 | 160 | 0.020 |
Why?
| | Inflammation | 1 | 2019 | 2870 | 0.020 |
Why?
| | Prevalence | 1 | 2015 | 2839 | 0.020 |
Why?
| | Ecosystem | 1 | 2013 | 591 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2021 | 17149 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 174 | 0.020 |
Why?
| | Toll-Like Receptor 2 | 1 | 2008 | 127 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2010 | 1078 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2008 | 306 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2010 | 2019 | 0.010 |
Why?
| | Spleen | 1 | 2008 | 510 | 0.010 |
Why?
| | T-Lymphocyte Subsets | 1 | 2008 | 412 | 0.010 |
Why?
| | Adult | 2 | 2019 | 40489 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2009 | 1246 | 0.010 |
Why?
| | Sex Characteristics | 1 | 2010 | 776 | 0.010 |
Why?
| | Body Mass Index | 1 | 2012 | 2419 | 0.010 |
Why?
| | Chronic Disease | 1 | 2010 | 1810 | 0.010 |
Why?
| | Sperm Head | 1 | 2003 | 5 | 0.010 |
Why?
| | Microscopy, Immunoelectron | 1 | 2003 | 43 | 0.010 |
Why?
| | Meiosis | 1 | 2003 | 101 | 0.010 |
Why?
| | DNA Primers | 1 | 2003 | 507 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2008 | 1468 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2009 | 2815 | 0.010 |
Why?
| | Risk Factors | 1 | 2015 | 10796 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2003 | 1047 | 0.010 |
Why?
| | Cell Nucleus | 1 | 2003 | 592 | 0.010 |
Why?
| | Transcription Factors | 1 | 2008 | 1726 | 0.010 |
Why?
| | Genotype | 1 | 2003 | 1847 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2007 | 2350 | 0.010 |
Why?
| | Asthma | 1 | 2008 | 1774 | 0.010 |
Why?
| | Cohort Studies | 1 | 2007 | 5957 | 0.010 |
Why?
|
|
Bai's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|